Construction of Prognostic Markers for Gastric Cancer and Comprehensive Analysis of Pyroptosis-related Long Non-coding RNAs

Overview

Journal World J Gastrointest Surg

Publisher Baishideng Publishing Group

Specialty Gastroenterology

Date 2024 Aug 1

PMID 39087128

Authors

Yu Wang

Di Li

Jing Xun

Yu Wu

Hong-Lei Wang

Affiliations

Soon will be listed here.

Abstract

Background: China's most frequent malignancy is gastric cancer (GC), which has a very poor survival rate, and the survival rate for patients with advanced GC is dismal. Pyroptosis has been connected to the genesis and development of cancer. The function of pyroptosis-related long non-coding RNAs (PRLs) in GC, on the other hand, remains uncertain.

Aim: To explore the construction and comprehensive analysis of the prognostic characteristics of long non-coding RNA (lncRNA) related to pyroptosis in GC patients.

Methods: The TCGA database provided us with 352 stomach adenocarcinoma samples, and we obtained 28 pyroptotic genes from the Reactome database. We examined the correlation between lncRNAs and pyroptosis using the Pearson correlation coefficient. Prognosis-related PRLs were identified through univariate Cox analysis. A predictive signature was constructed using stepwise Cox regression analysis, and its reliability and independence were assessed. To facilitate clinical application, a nomogram was created based on this signature. we analyzed differences in immune cell infiltration, immune function, and checkpoints between the high-risk group (HRG) and low-risk group (LRG).

Results: Five hundred and twenty-three PRLs were screened from all lncRNAs (absolute correlation coefficient > 0.4, < 0.05). Nine PRLs were included in the risk prediction signature that was created through stepwise Cox regression analysis. We determined the risk score for GC patients and employed the median value as the dividing line between HRG and LRG. The ability of the risk signature to predict the overall survival (OS) of GC is demonstrated by the Kaplan-Meier analysis, risk curve, receiver operating characteristic curve, and decision curve analysis curve. The risk signature was shown to be an independent prognostic factor for OS in both univariate and multivariate Cox regression analyses. HRG showed a more efficient local immune response or modulation compared to LRG, as indicated by the predicted signal pathway analysis and examination of immune cell infiltration, function, and checkpoints ( < 0.05).

Conclusion: In general, we have created a brand-new prognostic signature using PRLs, which may provide ideas for immunotherapy in patients with GC.

Citing Articles

Development of a Novel Prognostic Model for Lung Adenocarcinoma Utilizing Pyroptosis-Associated LncRNAs.

Bai H, Li T, Sun L, Zhang J, Kang X, Qu Y Anal Cell Pathol (Amst). 2025; 2025():4488139.

PMID: 39834603 PMC: 11745560. DOI: 10.1155/ancp/4488139.

References

Cookson B, Brennan M . Pro-inflammatory programmed cell death. Trends Microbiol. 2001; 9(3):113-4. DOI: 10.1016/s0966-842x(00)01936-3. View

Tan Z . Recent Advances in the Surgical Treatment of Advanced Gastric Cancer: A Review. Med Sci Monit. 2019; 25:3537-3541. PMC: 6528544. DOI: 10.12659/MSM.916475. View

Tu S, Bhagat G, Cui G, Takaishi S, Kurt-Jones E, Rickman B . Overexpression of interleukin-1beta induces gastric inflammation and cancer and mobilizes myeloid-derived suppressor cells in mice. Cancer Cell. 2008; 14(5):408-19. PMC: 2586894. DOI: 10.1016/j.ccr.2008.10.011. View

Han X, Zhang S . Role of Long Non-Coding RNA LINC00641 in Cancer. Front Oncol. 2022; 11:829137. PMC: 8828736. DOI: 10.3389/fonc.2021.829137. View

Chowell D, Krishna C, Pierini F, Makarov V, Rizvi N, Kuo F . Evolutionary divergence of HLA class I genotype impacts efficacy of cancer immunotherapy. Nat Med. 2019; 25(11):1715-1720. PMC: 7938381. DOI: 10.1038/s41591-019-0639-4. View

Becht E, Giraldo N, Lacroix L, Buttard B, Elarouci N, Petitprez F . Estimating the population abundance of tissue-infiltrating immune and stromal cell populations using gene expression. Genome Biol. 2016; 17(1):218. PMC: 5073889. DOI: 10.1186/s13059-016-1070-5. View

Yan H, Bu P . Non-coding RNA in cancer. Essays Biochem. 2021; 65(4):625-639. PMC: 8564738. DOI: 10.1042/EBC20200032. View

Dustin M . The immunological synapse. Cancer Immunol Res. 2014; 2(11):1023-33. PMC: 4692051. DOI: 10.1158/2326-6066.CIR-14-0161. View

Ye Y, Ge O, Zang C, Yu L, Eucker J, Chen Y . LINC01094 Predicts Poor Prognosis in Patients With Gastric Cancer and is Correlated With EMT and Macrophage Infiltration. Technol Cancer Res Treat. 2022; 21:15330338221080977. PMC: 8905065. DOI: 10.1177/15330338221080977. View

10.

Lv X, Zhang L, Huang R, Song W . A clinical exploration of neoadjuvant chemotherapy with tegafur, gimeracil, and oteracil potassium capsules combined with oxaliplatin for advanced gastric cancer. Int J Clin Exp Med. 2016; 8(10):19030-6. PMC: 4694429. View

11.

Li X, Yu Q . Linc01094 Accelerates the Growth and Metastatic-Related Traits of Glioblastoma by Sponging miR-126-5p. Onco Targets Ther. 2020; 13:9917-9928. PMC: 7547807. DOI: 10.2147/OTT.S263091. View

12.

Gong J, Ma L, Peng C, Liu J . LncRNA MAGI2-AS3 acts as a tumor suppressor that attenuates non-small cell lung cancer progression by targeting the miR-629-5p/TXNIP axis. Ann Transl Med. 2022; 9(24):1793. PMC: 8756221. DOI: 10.21037/atm-21-6466. View

13.

Sannino F, Sansone C, Galasso C, Kildgaard S, Tedesco P, Fani R . Pseudoalteromonas haloplanktis TAC125 produces 4-hydroxybenzoic acid that induces pyroptosis in human A459 lung adenocarcinoma cells. Sci Rep. 2018; 8(1):1190. PMC: 5775203. DOI: 10.1038/s41598-018-19536-2. View

14.

Li T, Fan J, Wang B, Traugh N, Chen Q, Liu J . TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells. Cancer Res. 2017; 77(21):e108-e110. PMC: 6042652. DOI: 10.1158/0008-5472.CAN-17-0307. View

15.

Hung C, Wang L, Yu Y, Chen H, Srivastava S, Petrovics G . A long noncoding RNA connects c-Myc to tumor metabolism. Proc Natl Acad Sci U S A. 2014; 111(52):18697-702. PMC: 4284533. DOI: 10.1073/pnas.1415669112. View

16.

Wang Z, Cao L, Zhou S, Lyu J, Gao Y, Yang R . Construction and Validation of a Novel Pyroptosis-Related Four-lncRNA Prognostic Signature Related to Gastric Cancer and Immune Infiltration. Front Immunol. 2022; 13:854785. PMC: 8980360. DOI: 10.3389/fimmu.2022.854785. View

17.

Tragante V, Moore J, Asselbergs F . The ENCODE project and perspectives on pathways. Genet Epidemiol. 2014; 38(4):275-80. DOI: 10.1002/gepi.21802. View

18.

Gou M, Qian N, Zhang Y, Wei L, Fan Q, Wang Z . Construction of a nomogram to predict the survival of metastatic gastric cancer patients that received immunotherapy. Front Immunol. 2022; 13:950868. PMC: 9549034. DOI: 10.3389/fimmu.2022.950868. View

19.

Yang J, Nie J, Ma X, Wei Y, Peng Y, Wei X . Targeting PI3K in cancer: mechanisms and advances in clinical trials. Mol Cancer. 2019; 18(1):26. PMC: 6379961. DOI: 10.1186/s12943-019-0954-x. View

20.

Wang W, Pei Q, Wang L, Mu T, Feng H . Construction of a Prognostic Signature of 10 Autophagy-Related lncRNAs in Gastric Cancer. Int J Gen Med. 2022; 15:3699-3710. PMC: 8994655. DOI: 10.2147/IJGM.S348943. View